HSPA1A Protein <table class="infobox infobox-protein">
HSPA1A Protein (Hsp70-1A)
...
HSPA1A Protein <table class="infobox infobox-protein">
HSPA1A Protein (Hsp70-1A)
Pathway Diagram
Mermaid diagram (expand to render)
Introduction HSPA1A (Heat Shock 70 kDa Protein 1A) , also known as Hsp70-1A , is the prototypical stress-inducible molecular chaperone encoded by the [HSPA1A](/genes/hspa1a) gene. As one of the most studied [heat shock proteins](/entities/heat-shock-proteins), HSPA1A plays essential roles in protein homeostasis, cellular stress protection, and cell survival. It is dramatically upregulated in response to various stresses including heat, oxidative stress, and proteotoxic challenges. HSPA1A has emerged as a critical protein in neurodegenerative disease research due to its ability to prevent and clear toxic protein aggregates [1].
Structure HSPA1A has the canonical Hsp70 domain architecture:
N-terminal ATPase Domain (~44 kDa)
Binds and hydrolyzes ATP
Regulates substrate binding cycle
Contains the characteristic Walker A and B motifs
Substrate-binding Domain (~25 kDa)
Peptide-binding cavity with lid structure
Binds hydrophobic peptide segments
EEVD motif at C-terminus for co-chaperone binding
Interdomain Linker
Connects ATPase and substrate-binding domains
Allosterically couples ATP hydrolysis to substrate binding
Normal Function
Molecular Chaperone Activity HSPA1A performs ATP-dependent protein folding:
Substrate recognition : Binds hydrophobic regions of unfolded proteinsFolding assistance : Facilitates proper protein foldingAggregation prevention : Prevents toxic protein aggregate formationRefolding : Can rescue denatured proteinsStress Response As the major stress-inducible Hsp70:
Heat shock response : Primary effector of HSF1 activationOxidative stress protection : Counteracts [ROS](/entities/reactive-oxygen-species)-induced damageProteotoxic stress : Manages misfolded protein accumulationProtein Quality Control HSPA1A is central to cellular proteostasis:
[Ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) : Co-operates with E3 ubiquitin ligases[Autophagy](/entities/autophagy) : Regulates aggrephagy and mitophagyProtein triage : Decides between refolding, degradation, or sequestrationAnti-apoptotic Function HSPA1A has well-characterized anti-apoptotic effects:
Inhibits caspase activation
Blocks apoptosome formation
Stabilizes anti-apoptotic proteins
Role in Neurodegeneration
Alzheimer's Disease HSPA1A plays multiple protective roles in AD:
Amyloid-β management :
Binds to [Aβ](/proteins/amyloid-beta) peptides, preventing aggregation [2]
Facilitates Aβ clearance via proteasome and autophagy
Protects [neurons](/entities/neurons) from Aβ-induced toxicity
[Tau](/proteins/tau) pathology :
Interacts with hyperphosphorylated tau
Facilitates tau clearance
Protects against tau-induced neurodegeneration
Neuroprotection :
Anti-apoptotic functions
Oxidative stress mitigation
Mitochondrial protection
Parkinson's Disease HSPA1A is particularly important in PD:
[α-Synuclein](/proteins/alpha-synuclein) handling :
Binds to [alpha-synuclein](/proteins/alpha-synuclein) monomers and oligomers [3]
Inhibits α-synuclein fibrillization
Facilitates autophagic clearance of α-synuclein aggregates
Mitochondrial function :
Protects against mitochondrial toxins (e.g., MPTP, 6-OHDA)
Maintains mitochondrial protein quality
Supports mitophagy
Dopaminergic neuron survival :
Specifically protects dopaminergic neurons
Upregulated in PD brains (compensatory response)
Amyotrophic Lateral Sclerosis (ALS) In ALS:
Handles mutant SOD1 aggregates
Involved in stress granule dynamics
Motor neuron protection
Huntington's Disease In Huntington's disease:
Binds to mutant [huntingtin](/proteins/huntingtin) [Huntingtin](/proteins/huntingtin) [4]
Reduces polyglutamine aggregation
Improves neuronal survival in models
Therapeutic Implications HSPA1A is a major therapeutic target:
Pharmacological Modulation Small molecules that increase HSPA1B expression:
Geranylgeranylacetone (GGA) : Induces HSPA1A expressionArimoclomol : HSP co-inducer in clinical trials for ALS17-DMAG : HSP90 inhibitor (indirect HSPA1A inducer)Gene Therapy
AAV-mediated HSPA1A delivery to brain
Viral vector-based approaches
Protein-based Approaches
Recombinant Hsp70 administration
Cell-permeable Hsp70 variants
Research Findings Key developments:
HSPA1A is consistently upregulated in neurodegenerative disease brains
Genetic variants of HSPA1A modify disease risk and progression
HSPA1A-based therapies show promise in preclinical models
See Also
[HSPA1A Gene](/genes/hspa1a)
[HSPA1B Protein](/proteins/hspa1b-protein)
[HSP70 Protein Family](/proteins/hsp70-protein-family)
[Molecular Chaperones](/mechanisms/protein-quality-control-network)
[Alzheimer's Disease Pathogenesis](/mechanisms/alzheimers-disease-pathogenesis)
[Parkinson's Disease Pathogenesis](/mechanisms/parkinsons-disease-pathogenesis)
References
[Stefan et al., HSP70 in neurodegeneration (2019) (2019)](https://doi.org/10.1016/j.tcb.2019.01.006)
[Evans et al., HSP70 and amyloid-beta (2006) (2006)](https://doi.org/10.1074/jbc.M513953200)
[S里 et al., HSP70 and alpha-synuclein (2012) (2012)](https://doi.org/10.1074/jbc.M112.387530)
[Muchowski et al., HSP70 in polyglutamine disease (2002) (2002)](https://doi.org/10.1073/pnas.032534799)
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
[Heat Shock Protein 70 Disaggregase Amplification](/hypothesis/h-5dbfd3aa) — <span style="color:#ffd54f;font-weight:600">0.51</span> · Target: HSPA1A
[Chaperone-Mediated APOE4 Refolding Enhancement](/hypothesis/h-637a53c9) — <span style="color:#ffd54f;font-weight:600">0.48</span> · Target: HSPA1A, HSP90AA1, DNAJB1, FKBP5
[Microbial Metabolite-Mediated α-Synuclein Disaggregation](/hypothesis/h-74777459) — <span style="color:#ffd54f;font-weight:600">0.43</span> · Target: SNCA, HSPA1A, DNMT1
Pathway Diagram The following diagram shows the key molecular relationships involving HSPA1A Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description